Atrial natriuretic peptide (ANP) gene promoter variant and increased susceptibility to early development of hypertension in humans

Journal of Human Hypertension

Volumn 21, Issue 10, 2007, Pages 822-824

  Rubattu, S ^a,b   Evangelista, A ^b   Barbato, D ^b   Barba, G ^c   Stanzione, R ^b   Iacone, R ^d   Volpe, M ^a,b   Strazzullo, P ^d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS NEUROMED   (Italy)

^c CNR   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATRIAL NATRIURETIC FACTOR; GENOMIC DNA;

ADULT; AGE; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CAUCASIAN; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FOLLOW UP; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; HYPERTENSION; ITALY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; WILD TYPE;

ADULT; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; ITALY; LONGITUDINAL STUDIES; MALE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS (GENETICS); VARIATION (GENETICS);

EID: 34548821252     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1002228     Document Type: Article

References (12)

1. Ward R. Familial aggregation and genetic epidemiology of blood pressure. In: Laragh JH, Brenner BM (eds). Hypertension: Pathphysiology, Diagnosis and Management. Raven Press : New York, 1990, pp 81-100.
2. Lifton RP, Gharavi AG, Geller DS, Molecular mechanisms of human hypertension. Cell 2001; 104: 545-556.
3. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 339: 321-328.
4. John SW, Krege JH, Oliver PM, Hagaman JR, Hodgin JB, Pang SC et al. Genetic decreases in atrial natriuretic peptide and salt sensitive hypertension. Science 1995; 267: 679-683.
5. Steinhelper ME, Cochrane KL, Field IJ. Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes. Hypertension 1990; 16: 301-307.
6. Oliver PM, Fox JE, Kim R, Rockman HA, Kim HS, Reddick RL et al. Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci USA 1997; 94 14730-14735.
7. Schillinger KJ, Tsai SY, Taffet GE, Reddy AK, Marian AJ, Entman ML et al. Regulatable atrial natriuretic peptide gene therapy for hypertension. Proc Natl Acad Sci USA 2005; 102: 13789-13794.
8. Kato N, Sugiyama T, Murita H, Nabika. T, Kurihara H, Yamori T et al. Genetic analysis of the atrial natriuretic peptide gene in essential hypertension. Clin Sci 2000; 98: 251-258.
9. Beige J, Ringel J, Hohenbleicher H, Rubattu S, Kreutz R, Sharma AM. HpaII polymorphism of the atrial natriuretic peptide gene and essential hypertension in whites. Am J Hypertens 1997; 10: 1316-1318.
10. Rubattu S, Bigatti G, Evangelista A, Lanzani C, Stanzione R, Zagato L et al. Association of atrial natriuretic peptide and type-A natriuretic peptide receptor gene polimorphisms with left ventricular mass in human essential hypertension. J Am Coll Cardiol 2006; 48: 499-505.
11. Strazzullo P, Iacone R, Iacoviello L, Russo O, Barba G, Russo P et al. Genetic variation in the renin-angiotengin system and the development of obesity in men: The Olivetti Prospective Heart Study. Ann Int Med 2003; 138: 17-23.
12. Rubattu S, Stanzione R, Di Angelantonio E, Zanda B, Evangelista A, Tarasi D et al. Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans. Stroke 2004; 35: 814-818.